Hsu Chueh-Hsuan, Yu Yung-Luen
Graduate Institute of Biomedical Sciences, College of Medicine, China Medical University, Taichung, 40402, Taiwan.
Institute of Translational Medicine and New Drug Development, Taichung, 40402, Taiwan.
Cancer Cell Int. 2023 Nov 22;23(1):289. doi: 10.1186/s12935-023-03143-x.
Protein tripartite motif-containing 21 (TRIM21/Ro52), an E3 ubiquitin ligase, is an essential regulator of innate immunity, and its dysregulation is closely associated with the development of autoimmune diseases, predominantly systemic lupus erythematosus (SLE) and primary Sjögren's syndrome (pSS). TRIM21 /Ro52 also features anti-cancer and carcinogenic functions according to different malignancies. The interconnected role of TRIM21/Ro52 in regulating autoimmunity and cell metabolism in autoimmune diseases and malignancies is implicated. In this review, we summarize current findings on how TRIM21/Ro52 affects inflammation and tumorigenesis, and investigate the relationship between TRIM21/Ro52 expression and the formation of lymphoma and breast cancer in SLE and pSS populations.
含三联基序蛋白21(TRIM21/Ro52)是一种E3泛素连接酶,是先天性免疫的重要调节因子,其失调与自身免疫性疾病的发展密切相关,主要是系统性红斑狼疮(SLE)和原发性干燥综合征(pSS)。根据不同的恶性肿瘤,TRIM21/Ro52还具有抗癌和致癌功能。TRIM21/Ro52在自身免疫性疾病和恶性肿瘤中调节自身免疫和细胞代谢的相互关联作用也有涉及。在这篇综述中,我们总结了目前关于TRIM21/Ro52如何影响炎症和肿瘤发生的研究结果,并探讨了SLE和pSS人群中TRIM21/Ro52表达与淋巴瘤和乳腺癌形成之间的关系。